Jyothy Labs (JYOTHYLAB)₹202.69+1.19%Household Products
In the Mar 2026 quarter (standalone), Jyothy Labs reported sales of ₹716 Cr, up 7.7% from Mar 2025, and net profit of ₹67.80 Cr, down 11.8% year on year. For the year to Mar 2026, sales were ₹2,942 Cr and net profit ₹332 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 685 | 731 | 677 | 659 | 740 | 732 | 704 | 665 | 750 | 735 | 739 | 716 |
| Expenses | 569 | 595 | 558 | 551 | 608 | 595 | 587 | 554 | 626 | 618 | 629 | 621 |
| Operating Profit | 118 | 135 | 119 | 108 | 134 | 138 | 116 | 112 | 124 | 118 | 111 | 97.12 |
| OPM % | 17.0% | 18.0% | 18.0% | 16.0% | 18.0% | 19.0% | 16.0% | 17.0% | 17.0% | 16.0% | 15.0% | 13.0% |
| Other Income | 17.02 | 13.01 | 11.01 | 13.01 | 13.99 | 13.01 | 14.01 | 12.01 | 18.99 | 17.02 | 14.99 | 16.02 |
| Interest | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 1.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| Depreciation | 11.97 | 11.97 | 12.96 | 12.96 | 12.96 | 13.96 | 13.95 | 14.95 | 14.95 | 14.94 | 15.96 | 15.94 |
| Profit before tax | 121 | 135 | 115 | 107 | 132 | 136 | 114 | 108 | 128 | 119 | 109 | 96.03 |
| Tax % | 21.0% | 23.0% | 21.0% | 27.0% | 23.0% | 23.0% | 23.0% | 28.0% | 24.0% | 26.0% | 26.0% | 29.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −2.99 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 95.69 | 104 | 90.75 | 77.83 | 102 | 105 | 86.72 | 76.84 | 96.80 | 87.80 | 80.80 | 67.80 |
| EPS (Rs) | 2.63 | 2.85 | 2.49 | 2.14 | 2.78 | 2.87 | 2.39 | 2.11 | 2.65 | 2.40 | 2.22 | 1.85 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,540 | 1,630 | 1,623 | 1,767 | 1,664 | 1,882 | 2,191 | 2,482 | 2,753 | 2,840 | 2,942 | 2,941 |
| Expenses | 1,313 | 1,370 | 1,361 | 1,483 | 1,414 | 1,568 | 1,944 | 2,165 | 2,274 | 2,344 | 2,495 | 2,494 |
| Operating Profit | 229 | 261 | 264 | 286 | 250 | 317 | 248 | 316 | 480 | 500 | 451 | 450 |
| OPM % | 15.0% | 16.0% | 16.0% | 16.0% | 15.0% | 17.0% | 11.0% | 13.0% | 17.0% | 18.0% | 15.0% | 15.3% |
| Other Income | 15.02 | 11.01 | 42.99 | 27.04 | 15.99 | −4.01 | 18.02 | 47.05 | 54.03 | 51.01 | 67.07 | 67.02 |
| Interest | 55.79 | 50.77 | 41.84 | 27.87 | 24.91 | 11.96 | 11.95 | 12.94 | 4.98 | 5.97 | 4.98 | 3.96 |
| Depreciation | 53.79 | 54.85 | 56.85 | 57.82 | 75.76 | 77.72 | 88.74 | 49.84 | 49.86 | 55.81 | 60.76 | 61.79 |
| Profit before tax | 133 | 166 | 208 | 228 | 166 | 223 | 166 | 299 | 479 | 490 | 451 | 452 |
| Tax % | 44.0% | −22.0% | 23.0% | 15.0% | 5.0% | 15.0% | 16.0% | 20.0% | 23.0% | 24.0% | 26.0% | — |
| Exceptional items | 3.99 | 0.00 | 15.97 | 0.99 | −1.99 | −19.98 | 0.99 | 19.96 | 12.98 | 4.99 | 10.98 | 0.00 |
| Net Profit | 74.85 | 202 | 161 | 193 | 158 | 189 | 139 | 239 | 369 | 370 | 332 | 333 |
| EPS (Rs) | 2.07 | 5.57 | 4.43 | 5.27 | 4.30 | 5.19 | 3.79 | 6.53 | 10.08 | 10.12 | 9.08 | 9.12 |
| Dividend payout % | 122.0% | 54.0% | 6.0% | 56.9% | 70.0% | 77.0% | 66.0% | 46.0% | 35.0% | 35.0% | 39.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 17.98 | 17.97 | 17.99 | 17.99 | 36.99 | 37.01 | 37.01 | 36.98 | 36.96 | 36.97 | 36.98 | 36.94 |
| Reserves | 942 | 453 | 634 | 664 | 816 | 706 | 896 | 695 | 844 | 1,103 | 1,344 | 1,548 |
| Borrowings | 518 | 401 | 451 | 479 | 217 | 221 | 96.86 | 171 | 46.94 | 50.91 | 60.92 | 51.84 |
| Other Liabilities | 438 | 462 | 256 | 298 | 343 | 327 | 395 | 450 | 466 | 543 | 583 | 615 |
| Total Liabilities | 1,915 | 1,334 | 1,360 | 1,459 | 1,412 | 1,290 | 1,425 | 1,353 | 1,393 | 1,732 | 2,024 | 2,250 |
| Fixed Assets | 570 | 538 | 542 | 490 | 472 | 485 | 457 | 441 | 435 | 445 | 461 | 505 |
| CWIP | 5.01 | 8.01 | 8.02 | 15.04 | 14.03 | 24.07 | 10.02 | 8.02 | 15.04 | 13.02 | 22.05 | 10.02 |
| Investments | 408 | 204 | 154 | 245 | 241 | 139 | 141 | 5.98 | 5.99 | 197 | 455 | 504 |
| Other Assets | 933 | 583 | 656 | 709 | 685 | 643 | 816 | 899 | 936 | 1,077 | 1,086 | 1,231 |
| Inventories | 180 | 183 | 194 | 187 | 201 | 222 | 276 | 295 | 299 | 281 | 327 | 343 |
| Trade receivables | 50.87 | 88.74 | 112 | 156 | 148 | 120 | 86.72 | 137 | 132 | 196 | 273 | 256 |
| Cash & equivalents | 64.95 | 54.99 | 94.90 | 127 | 87.97 | 19.98 | 191 | 210 | 283 | 165 | 142 | 310 |
| Total Assets | 1,915 | 1,334 | 1,360 | 1,459 | 1,412 | 1,290 | 1,425 | 1,353 | 1,393 | 1,732 | 2,024 | 2,250 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 158 | 195 | 166 | 251 | 305 | 165 | 408 | 201 | 328 | 457 | 311 | 411 |
| Cash from investing activity | 0.00 | 97.24 | −20.06 | −81.22 | 25.07 | 72.21 | −150 | −29.08 | −48.18 | −345 | −162 | −278 |
| Cash from financing activity | −53.89 | −300 | −127 | −149 | −315 | −297 | −196 | −166 | −250 | −135 | −157 | −160 |
| Net cash flow | 103 | −6.99 | 17.96 | 20.98 | 12.98 | −59.91 | 62.95 | 5.99 | 29.95 | −20.96 | −6.99 | −24.95 |
| Capex | 5.99 | 25.01 | 56.08 | 36.03 | 38.99 | 39.05 | 25.01 | 26.02 | 35.02 | 37.02 | 58.03 | 67.01 |
| Free cash flow | 153 | 172 | 110 | 257 | 267 | 126 | 385 | 180 | 318 | 445 | 254 | 347 |
| CFO / OP % | 119.0% | 108.0% | 75.0% | 105.0% | 121.0% | 80.9% | 138.9% | 93.9% | 122.0% | 112.0% | 81.9% | 105.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 12 | 20 | 24 | 34 | 30 | 25 | 16 | 22 | 18 | 25 | 34 | 31 |
| Inventory days | 87 | 81 | 80 | 79 | 76 | 91 | 101 | 84 | 76 | 73 | 84 | 80 |
| Days payable | 62 | 69 | 60 | 62 | 66 | 52 | 69 | 67 | 55 | 72 | 75 | 74 |
| Cash conversion cycle | 37 | 32 | 45 | 51 | 39 | 64 | 47 | 39 | 40 | 27 | 44 | 37 |
| Working capital days | −34 | −109 | −78 | −78 | −21 | −10 | 8 | −4 | 11 | 38 | 38 | 14 |
| ROCE % | 11.0% | 16.0% | 22.1% | 20.1% | 23.0% | 19.1% | 26.1% | 18.0% | 31.1% | 44.1% | 37.1% | 29.0% |
For the Mar 2026 quarter, Jyothy Labs reported sales of ₹716 Cr, up 7.7% year on year and net profit of ₹67.80 Cr, down 11.8% year on year. The operating margin was 13.0%.
Jyothy Labs' sales for the year to Mar 2026 were ₹2,942 Cr; over the last twelve months they were ₹2,941 Cr.
Net profit for the year to Mar 2026 was ₹332 Cr, and ₹333 Cr over the last twelve months. Earnings per share over the same trailing period were ₹9.12.
Jyothy Labs reported borrowings of ₹51.84 Cr at Mar 2026, against cash and equivalents of ₹310 Cr.
Cash from operations was ₹411 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹347 Cr.